The listing below shows our latest News Items and is updated regularly. If you wish to post a news item please select the 'Post News' button on the right. The displayed news feed starts on 1st August 2016. Older items can be found here.
To 'Post Your News' use the button at the top right.
We are pleased to present below all posts archived in 'July, 2019'. If you still can't find what you are looking for, try using the search box.
Abingdon, UK; 29th July 2019 - OBN, the Membership organisation supporting the UK’s innovative life sciences companies, is pleased to announce Thermo Fisher Scientific as OBN’s new corporate sponsor.
Read the rest of entry »
Launched on 1st July, Swift R&D, the online and interactive R&D Tax Credit portal is the latest offering from TBAT Innovation Ltd – R&D Funding and Tax Credit specialists.
Oxford, UK, July 24 2019 - Following an architectural competition for a compelling contemporary design in 2018, involving four first-class international practices, and after open consultation with the local community, The Oxford Science Park has filed for detailed planning permission for a major new phase of development on its Plot 16.
AMSBIO has introduced a new range of homogeneous proximity assays, critical enzymes and small molecule inhibitors to assess the chemical adaptor function of Proteolysis Targeting Chimeras (PROTACs).
(Oxfordshire, UK and Pennsylvania and Maryland, US, 16 July 2019) Immunocore Limited, a leading T Cell Receptor (TCR) biotechnology company, today announce the publication of “Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma” in a special issue on uveal melanoma in Cancers, an international, peer-reviewed monthly journal.
Research Triangle Park, NC, USA and Cambridge, UK, and Dubai, UAE , July 16, 2019 -- Inivata, a leader in liquid biopsy, has signed a distribution agreement with IPS Genomix, part of the IPS Group, to provide cancer patients and partners in the Middle East and Africa with access to its InVisionFirst®-Lung and InVisionSeq™ liquid biopsy tests.
AMSBIO reports on the pioneering research published** in a collaborative effort between researchers in the School of Engineering, University of Newcastle and Department of Pharmacology, University of Cambridge, UK that has cited Biotinylated Hyaluronan Binding Protein (biotin-HABP) supplied by the company in its investigation into the cancer resistance of the naked mole-rat (NMR).
Despite improving survival rates, cancer is the leading cause of death in children and young people. There is a growing need for technology to support children and young people with cancer, as well as to support health care professionals to provide optimal care.
Invest Newcastle has welcomed a senior Cuban life science business delegation to the region for a two-day visit. They used this opportunity to show off the city’s life science strengths and world-leading universities.
AMSBIO announce new, best-in-class CAR-T cells, engineered CAR-T target cells, PBMC, cell media and activation beads in response to the rapid growth in research on the therapeutic uses of CAR-T cells.
OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.